Medpace Holdings, Inc.

MEDP · XNAS

CIK 1668397fmd_0WB00T70ADBSQ29N9Q4T9JS6W6Services · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	422	436	705	861	926	1,142	1,460	1,886	2,109	2,530
Selling, general and administrative	62	63	76	95	92	108	131	161	180	198
Operating income	52	65	101	127	167	199	279	337	447	535
Other non-operating income (expense)	(31)	(8)	(7)	(2)	1	3	4	(1)	29	7
Income before taxes	22	57	94	125	169	202	283	336	476	542
Income tax expense	9	18	21	24	23	20	37	53	72	91
Net income from continuing operations	13	39	73	100	145	182	245	283	404	451
Net income	13	39	73	100	145	182	245	283	404	451
Net income to common shareholders	13	39	73	100	145	181	245	283	404	451